LAWRENCE, Mass., June 12, 2014 /PRNewswire/ -- NxStage Medical, Inc. (NASDAQ: NXTM), a leading manufacturer of innovative dialysis products, is excited to share a current NxStage® System One™ user's story of freedom and discovery. When Don was diagnosed with kidney failure in 2012, it quickly became apparent that three-times-weekly in-center dialysis treatment would limit his time with his two passions – spending time with his young grandchildren and riding his motorcycle. Determined to reclaim the life he loved pre-dialysis, Don began more frequent home hemodialysis (HHD) treatment with the NxStage® System One™. More frequent HHD has helped Don reclaim his family life and get back to riding his motorcycle.
"Once I discovered NxStage and started more frequent at-home therapy with the System One, I felt myself come back from a really dark place," said Don. "One of my greatest joys is spending time with my grandchildren again, and all my goals are attainable now. It's a wonderful and life-changing feeling."
While on three-times-weekly in-center dialysis, Don's free time was spent recovering from treatment, limiting his time playing with his grandchildren and riding his motorcycle. After one year of travelling to and from the dialysis center, and a rigid treatment schedule that triggered feelings of depression and solitude, Don took matters into his own hands. He searched for an alternative and discovered NxStage's portable home hemodialysis machine. With help from his mother and trained care partner, Don now performs more frequent home hemodialysis and has experienced a positive change in his physical and mental health, as well as shorter recovery time after each treatment. These benefits have allowed Don to reclaim time with his family and his personal hobbies.
"Every day we strive to provide patients with the life changing benefits of our therapy. We are both humbled and inspired by what our patients tell us they are able to achieve and regain while on our therapy," stated Joe Turk, President of NxStage. "Their stories drive our continued innovation."
Hear Don share his journey with kidney failure in his video, http://ww2.nxstage.com/Don.html. To learn more about NxStage and the System One, visit www.nxstage.com or join the conversation on Facebook at facebook.com/NxStage, Twitter at @NxStage and YouTube at youtube.com/user/NxStage.
Despite the health benefits that more frequent home hemodialysis may provide to those with chronic kidney disease, this form of therapy is not for everyone. The reported benefits of home hemodialysis may not be experienced by all patients. The risks associated with hemodialysis treatments in any environment include, but are not limited to, high blood pressure, fluid overload, low blood pressure, heart-related issues, and vascular access complications. The medical devices used in hemodialysis therapies may add additional risks including air entering the bloodstream and blood loss due to clotting or accidental disconnection of the blood tubing set. Certain risks are unique to the home. Treatments at home are done without the presence of medical personnel and on-site technical support. Patients and their partners must be trained on what to do and how to get medical or technical help if needed.
About the NxStage System One The NxStage System One is the first and only truly portable hemodialysis system cleared for home use by the U.S. Food & Drug Administration (FDA). Its simplicity and revolutionary size (just over a foot tall) are intended to allow convenient use in patients' homes and give patients the freedom to travel with their therapy. When combined with the NxStage PureFlow SL Dialysis Preparation System, patients are able to further simplify, using ordinary tap water to create dialysis fluid. Unlike conventional hemodialysis systems, the System One requires no special infrastructure to operate. Under the guidance of their physician, patients can use the NxStage System One, with their trained partners, where, how and when it best meets their needs - at home or on vacation and at a medically appropriate treatment frequency. http://www.nxstage.com/.
About NxStage Medical NxStage Medical Inc. (Nasdaq: NXTM) is a medical device company, headquartered in Lawrence, Massachusetts, USA, that develops, manufactures and markets innovative products for the treatment of ESRD and acute kidney failure. For more information on NxStage and its products, please visit the Company's website at www.nxstage.com.
Forward-Looking Statements This release contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. All statements contained in this release that are not clearly historical in nature are forward-looking, and the words "anticipate," "believe," "expect," "estimate," "plan," and similar expressions are generally intended to identify forward-looking statements. Actual results may differ materially from those indicated by these forward-looking statements as a result of various important factors including those that are discussed in NxStage's filings with the Securities and Exchange Commission, including its Quarterly Report on Form 10-Q for the quarter ended March 31, 2014. NxStage is under no obligation to (and expressly disclaims any such obligation to) update or alter its forward-looking statements, whether as a result of new information, future events or otherwise.
Media Contact: Meredith D'Agostino 451 Marketing, on behalf of NxStage Medical, Inc. email@example.com (516) 884-7162
SOURCE NxStage Medical Inc.